Kenneth Stokholm
CEO
Kenneth joined QPharma as CEO in 2009 and brings 25 years of pharmaceutical industry experience. He has served in several roles at Nordic Group, including SVP of Technical operations and Strategic Development. Prior to this, he spent eight years in several international positions with Xellia pharmaceuticals, incl GM China, and five years in different technical roles with Novo Nordisk. Kenneth holds an MSc in chemical engineering from the technical university of Denmark (DTU) and an executive MBA from HEC in Paris.
Christian Frandsen
CFO
Christian joined QPharma as Group CFO in 2020 and brings more than 15 years of pharmaceutical industry experience. He has served in several roles at Novo Nordisk, including CFO of Novo Nordisk Pharmatech A/S, Finance & Operations Director positions in Novo Nordisk Sweden and Mexico and various management roles in HQ procurement. Prior to this, he was employed at the Confederations of Danish Industries. Christian holds a Ma (Law) from University of Copenhagen and an executive MBA from Scandinavian Management Institute in Copenhagen (SIMI).
Joseph McCluskey
VP Operations
Joseph joined QPharma in May 2020 bringing with him over 20 years of pharmaceutical industry experience. Prior to joining QPharma Joseph has had a long career with Fresenius Kabi where he held various roles with increasing levels of responsibility, including heading up multiple sites across Scandinavia and Asia. He has also held headed up the internal API manufacturing for AstraZeneca in Sweden. Joseph holds an MSc in Manufacturing from the Open University UK and BSc in Engineering Systems from Edinburgh Napier University.
Wouter de Graaff
Director R&D
Wouter is a seasoned leader in controlled release drug delivery and inventor of more than 15 drug delivery-related patents. Before joining QPharma in 2015 he headed the pharmaceutical development of polymer-based delivery systems within MSD (Merck) and the legacy companies Schering Plough and Organon. At QPharma he is responsible for strategy and development. Wouter graduated from the University of Amsterdam and holds an MSc in chemical engineering.
Linda Rebert
Head of QC
Linda joined QPharma in April 2020 and have more than 20 years of experience, mainly in the pharmaceutical industry but also in the food ingredient industry. She has held several roles at Polypeptide Laboratories AB such a Development Chemist, Manager of Synthesis Department and Global Process Excellence Manager. Most recently, she worked as Lean Director in Chr. Hansen A/S. Linda has studied Chemical Engineering at Lund University and has a Black Belt certification in Lean Six Sigma.
Lotte Nyman Göransson
Head of QA
Lotte joined QPharma as Head of Quality Assurance in October 2019. She has 20 years of experience from the pharmaceutical industry in the areas of quality assurance, production and R&D. She started with development of biotech processes at AstraZeneca Biotech Lab and then continued to the field of consulting at NNE Pharmaplan in Denmark. Lotte later joined Xellia Pharmaceuticals where she held various positions, among them department manager of CQA. Her most recent position was at Bristol Myers Squibb in Switzerland working with Tech Transfers of Sterile Biologics. Lotte holds an MSc in chemical engineering from the Technical Institute of Technology in Lund.
Jan Frykman
Head of HR, IT and administration
Jan joined QPharma as CFO in 2008 and brings 32 years of CFO/HR Director experience from Scandinavian process industry. He has served in several roles at QPharma, including CFO for 12 years and now as HR/IT Director. Prior to this, he spent 20 years as CFO in a dairy ingredient industry, at former Kemikalia. Before that he was in industrial glue production within Lyckeby Industrial. Jan is also a part of the PRI Council (Försäkringsbolaget PRI Pensionsgaranti ). Jan holds an BSc in International Financing from Lund University.
